PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447087
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1447087
Cholesterol Test Market Forecasts to 2030 - Global Analysis By Product Type, Test Type, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Cholesterol Test Market is accounted for $6.84 billion in 2023 and is expected to reach $13.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. A cholesterol test is a diagnostic procedure aimed at measuring the levels of cholesterol in the blood. It assesses various types of cholesterol, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, which are essential for evaluating cardiovascular health. Typically conducted through a blood sample, cholesterol testing helps identify individuals at risk of developing heart disease or experiencing cardiovascular events.
According to the World Health Organization (WHO), in 2022, over 650 million adults were obese.
Market Dynamics:
Driver:
Rising prevalence of cardiovascular diseases
Cardiovascular diseases, including heart attacks and strokes, are leading causes of morbidity and mortality globally. High cholesterol levels are a major risk factor for these diseases. As the prevalence of cardiovascular diseases continues to rise, there is a growing need for cholesterol testing. Cholesterol testing helps in assessing the levels of different cholesterol components, such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. Overall, the rising prevalence of cardiovascular diseases is a factor driving market demand.
Restraint:
High cost
The high costs associated with cholesterol testing procedures, including laboratory tests, diagnostic equipment, and professional fees, can create financial barriers for individuals, particularly those without adequate insurance coverage or access to healthcare services. Moreover, healthcare providers face challenges in balancing the need to provide affordable testing options with maintaining profitability and covering operational expenses. As a result, high costs present a significant threat to the cholesterol test market.
Opportunity:
Technological advancements
The integration of novel biomarkers and multiplex testing platforms enables comprehensive lipid profiling, providing a more holistic assessment of cardiovascular risk factors beyond traditional cholesterol measurements. Furthermore, advancements in laboratory-based cholesterol testing technologies have led to the introduction of automated analyzers and high-throughput systems, enhancing testing efficiency and scalability while reducing human error and operational costs.
Threat:
Limited awareness
Many individuals remain unaware of the importance of cholesterol testing in assessing their risk of heart disease and stroke, leading to low testing rates, especially among asymptomatic individuals. Additionally, misconceptions or misinformation about cholesterol testing procedures, perceived invasiveness, or discomfort associated with blood draws may further deter individuals from seeking testing. Therefore, limited awareness is a significant factor limiting market expansion.
Covid-19 Impact
The COVID-19 pandemic had a negative impact on the cholesterol test market. Initially, the focus of healthcare systems shifted towards managing the crisis, leading to disruptions in routine medical services, including cholesterol testing and preventive care. Many non-urgent medical appointments were postponed or cancelled, resulting in a decline in cholesterol screenings. Additionally, concerns about virus transmission prompted individuals to avoid healthcare facilities unless absolutely necessary, further reducing the number of people seeking cholesterol tests.
The test kits segment is expected to be the largest during the forecast period
The test kits segment is estimated to hold the largest share. These kits typically contain all the necessary components for conducting cholesterol tests outside of traditional laboratory settings. They often include test strips, lancets for blood sampling, and solutions or reagents required for analysis. Healthcare providers also rely on cholesterol test kits for rapid assessments during patient consultations or health screenings. Additionally, these kits offer quick results, allowing for timely interventions and treatment decisions.
The total cholesterol test segment is expected to have the highest CAGR during the forecast period
The total cholesterol test segment is anticipated to have lucrative growth during the forecast period. This test measures the total amount of cholesterol present in the blood, including both high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol, along with triglycerides. The total cholesterol test plays a critical role in preventive healthcare, providing valuable insights into an individual's lipid profile and overall cardiovascular health status.
Region with largest share:
North America commanded the largest market share during the extrapolated period owing to the robust healthcare infrastructure, advanced diagnostic technologies, and a high prevalence of cardiovascular disease risk factors. The region is home to numerous pharmaceutical and biotechnology companies engaged in developing innovative cholesterol-lowering medications and diagnostic technologies, driving market growth and innovation. Additionally, public health campaigns and educational efforts raise awareness about the importance of cholesterol management and healthy lifestyle choices, further driving demand for cholesterol testing services and products.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period. Countries in the Asia Pacific region are experiencing demographic shifts, including aging populations and the emergence of a middle-class segment with greater disposable income, driving demand for healthcare services, including cholesterol testing. Additionally, government initiatives aimed at addressing non-communicable diseases, including cardiovascular health promotion and disease prevention programs, further propel market growth in this region.
Key players in the market
Some of the key players in the Cholesterol Test Market include Thermo Fisher Scientific, Cell Biolabs, Inc., Randox Laboratories Ltd., Clinical Reference Laboratory, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Alere Inc., PTS Diagnostics, Eurofins Scientific, F. Hoffmann-La Roche AG, Horiba Ltd, Danaher Corp, Abbott Laboratories and Nova Biomedical.
Key Developments:
In December 2023, Randox Laboratories Ltd and Transgene entered into a scientific collaboration, with the aim of joining their competences to deliver a novel therapeutic approach to oncology therapies.
In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.
In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.
In November 2022, Danaher Corporation, a global science and technology innovator, announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.
Product Types Covered:
- Test Strips
- Test Kits
- Test Meters
- Other Product Types
Test Types Covered:
- High-Density Lipoprotein (HDL) Cholesterol
- Low-Density Lipoprotein (LDL) Cholesterol
- Total Cholesterol Test
- Triglycerides/VLDL Cholesterol Test
- Other Test Types
Distribution Channels Covered:
- Over the Counter
- Prescription Based
End Users Covered:
- Homecare
- Hospitals & Clinics
- Diagnostic Centers
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Cholesterol Test Market, By Product Type
- 5.1 Introduction
- 5.2 Test Strips
- 5.3 Test Kits
- 5.4 Test Meters
- 5.5 Other Product Types
6 Global Cholesterol Test Market, By Test Type
- 6.1 Introduction
- 6.2 High-Density Lipoprotein (HDL) Cholesterol
- 6.3 Low-Density Lipoprotein (LDL) Cholesterol
- 6.4 Total Cholesterol Test
- 6.5 Triglycerides/VLDL Cholesterol Test
- 6.6 Other Test Types
7 Global Cholesterol Test Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Over the Counter
- 7.3 Prescription Based
8 Global Cholesterol Test Market, By End User
- 8.1 Introduction
- 8.2 Homecare
- 8.3 Hospitals & Clinics
- 8.4 Diagnostic Centers
- 8.5 Other End Users
9 Global Cholesterol Test Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Thermo Fisher Scientific
- 11.2 Cell Biolabs, Inc.
- 11.3 Randox Laboratories Ltd.
- 11.4 Clinical Reference Laboratory, Inc.
- 11.5 Quest Diagnostics Incorporated
- 11.6 Laboratory Corporation of America Holdings
- 11.7 Alere Inc.
- 11.8 PTS Diagnostics
- 11.9 Eurofins Scientific
- 11.10 F. Hoffmann-La Roche AG
- 11.11 Horiba Ltd
- 11.12 Danaher Corp
- 11.13 Abbott Laboratories
- 11.14 Nova Biomedical
List of Tables
- Table 1 Global Cholesterol Test Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 3 Global Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 4 Global Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 5 Global Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 6 Global Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 7 Global Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 8 Global Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 9 Global Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 10 Global Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 11 Global Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 12 Global Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 13 Global Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 14 Global Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 15 Global Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 16 Global Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 17 Global Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 18 Global Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 19 Global Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 20 Global Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 21 North America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
- Table 22 North America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 23 North America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 24 North America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 25 North America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 26 North America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 27 North America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 28 North America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 29 North America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 30 North America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 31 North America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 32 North America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 33 North America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 34 North America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 35 North America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 36 North America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 37 North America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 38 North America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 39 North America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 40 North America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 41 Europe Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
- Table 42 Europe Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 43 Europe Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 44 Europe Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 45 Europe Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 46 Europe Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 47 Europe Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 48 Europe Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 49 Europe Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 50 Europe Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 51 Europe Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 52 Europe Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 53 Europe Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 54 Europe Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 55 Europe Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 56 Europe Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 57 Europe Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 58 Europe Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 59 Europe Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 60 Europe Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 61 Asia Pacific Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
- Table 62 Asia Pacific Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 63 Asia Pacific Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 64 Asia Pacific Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 65 Asia Pacific Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 66 Asia Pacific Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 67 Asia Pacific Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 68 Asia Pacific Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 69 Asia Pacific Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 70 Asia Pacific Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 71 Asia Pacific Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 72 Asia Pacific Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 73 Asia Pacific Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 74 Asia Pacific Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 75 Asia Pacific Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 76 Asia Pacific Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 77 Asia Pacific Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 78 Asia Pacific Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 79 Asia Pacific Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 80 Asia Pacific Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 81 South America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
- Table 82 South America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 83 South America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 84 South America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 85 South America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 86 South America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 87 South America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 88 South America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 89 South America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 90 South America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 91 South America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 92 South America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 93 South America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 94 South America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 95 South America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 96 South America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 97 South America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 98 South America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 99 South America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 100 South America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 101 Middle East & Africa Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
- Table 102 Middle East & Africa Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
- Table 103 Middle East & Africa Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
- Table 104 Middle East & Africa Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
- Table 105 Middle East & Africa Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
- Table 106 Middle East & Africa Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
- Table 107 Middle East & Africa Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
- Table 108 Middle East & Africa Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
- Table 109 Middle East & Africa Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
- Table 110 Middle East & Africa Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
- Table 111 Middle East & Africa Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
- Table 112 Middle East & Africa Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 113 Middle East & Africa Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 114 Middle East & Africa Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
- Table 115 Middle East & Africa Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
- Table 116 Middle East & Africa Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
- Table 117 Middle East & Africa Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
- Table 118 Middle East & Africa Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
- Table 119 Middle East & Africa Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
- Table 120 Middle East & Africa Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
